126 related articles for article (PubMed ID: 19234610)
21. Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study.
Allen RC; Brown SP
mBio; 2019 Sep; 10(5):. PubMed ID: 31530673
[TBL] [Abstract][Full Text] [Related]
22. Unpredictable repeatability in molecular evolution.
Das SG; Krug J
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2209373119. PubMed ID: 36122210
[TBL] [Abstract][Full Text] [Related]
23. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
[TBL] [Abstract][Full Text] [Related]
24. Collateral sensitivity constrains resistance evolution of the CTX-M-15 β-lactamase.
Rosenkilde CEH; Munck C; Porse A; Linkevicius M; Andersson DI; Sommer MOA
Nat Commun; 2019 Feb; 10(1):618. PubMed ID: 30728359
[TBL] [Abstract][Full Text] [Related]
25. Experimental evolution of gene duplicates in a bacterial plasmid model.
Holloway AK; Palzkill T; Bull JJ
J Mol Evol; 2007 Feb; 64(2):215-22. PubMed ID: 17211548
[TBL] [Abstract][Full Text] [Related]
26. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
[TBL] [Abstract][Full Text] [Related]
27. Reconstructing the genotype-to-fitness map for the bacterial chemotaxis network and its emergent behavioural phenotypes.
Nakauma A; van Doorn GS
J Theor Biol; 2017 May; 420():200-212. PubMed ID: 28322874
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of beta-lactamase genes in diarrheagenic Escherichia coli.
Singh T; Singh PK; Das S; Wani S; Jawed A; Dar SA
Sci Rep; 2019 Mar; 9(1):3626. PubMed ID: 30842518
[TBL] [Abstract][Full Text] [Related]
29. Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes.
Palmer AC; Toprak E; Baym M; Kim S; Veres A; Bershtein S; Kishony R
Nat Commun; 2015 Jun; 6():7385. PubMed ID: 26060115
[TBL] [Abstract][Full Text] [Related]
30. Predicting evolution by in vitro evolution requires determining evolutionary pathways.
Hall BG
Antimicrob Agents Chemother; 2002 Sep; 46(9):3035-8. PubMed ID: 12183265
[TBL] [Abstract][Full Text] [Related]
31. Analysis of epistatic interactions and fitness landscapes using a new geometric approach.
Beerenwinkel N; Pachter L; Sturmfels B; Elena SF; Lenski RE
BMC Evol Biol; 2007 Apr; 7():60. PubMed ID: 17433106
[TBL] [Abstract][Full Text] [Related]
32. Rational evolutionary design: the theory of in vitro protein evolution.
Voigt CA; Kauffman S; Wang ZG
Adv Protein Chem; 2000; 55():79-160. PubMed ID: 11050933
[TBL] [Abstract][Full Text] [Related]
33. Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor.
Russ D; Glaser F; Shaer Tamar E; Yelin I; Baym M; Kelsic ED; Zampaloni C; Haldimann A; Kishony R
Nat Commun; 2020 Apr; 11(1):2029. PubMed ID: 32332717
[TBL] [Abstract][Full Text] [Related]
34. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
Huseby DL; Pietsch F; Brandis G; Garoff L; Tegehall A; Hughes D
Mol Biol Evol; 2017 May; 34(5):1029-1039. PubMed ID: 28087782
[TBL] [Abstract][Full Text] [Related]
35. OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs.
Fröhlich C; Sørum V; Thomassen AM; Johnsen PJ; Leiros HS; Samuelsen Ø
mSphere; 2019 Mar; 4(2):. PubMed ID: 30918055
[TBL] [Abstract][Full Text] [Related]
36. Genomic investigations of evolutionary dynamics and epistasis in microbial evolution experiments.
Jerison ER; Desai MM
Curr Opin Genet Dev; 2015 Dec; 35():33-9. PubMed ID: 26370471
[TBL] [Abstract][Full Text] [Related]
37. The fitness consequences of synonymous mutations in Escherichia coli: Experimental evidence for a pleiotropic effect of translational selection.
Ballard A; Bieniek S; Carlini DB
Gene; 2019 Apr; 694():111-120. PubMed ID: 30738968
[TBL] [Abstract][Full Text] [Related]
38. Evolvability as a function of purifying selection in TEM-1 β-lactamase.
Stiffler MA; Hekstra DR; Ranganathan R
Cell; 2015 Feb; 160(5):882-892. PubMed ID: 25723163
[TBL] [Abstract][Full Text] [Related]
39. Probing the active site of beta-lactamase R-TEM1 by informational suppression.
Lenfant F; Labia R; Masson JM
Biochimie; 1990; 72(6-7):495-503. PubMed ID: 2124150
[TBL] [Abstract][Full Text] [Related]
40. Rapid in vivo evolution of a beta-lactamase using phagemids.
Long-McGie J; Liu AD; Schellenberger V
Biotechnol Bioeng; 2000 Apr; 68(1):121-5. PubMed ID: 10699880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
